China’s Medicines are Saving American Lives
The Economist reports that China is now the second largest producer of new pharmaceuticals, after the United States.
China has long been known for churning out generic drugs, supplying raw ingredients and managing clinical trials for the pharmaceutical world. But its drugmakers are now also at the cutting edge, producing innovative medicines that are cheaper than the ones they compete with.
… In September last year an experimental drug did what none had done before. In late-stage trials for non-small cell lung cancer, it nearly doubled the time patients lived without the disease getting worse—to 11.1 months, compared with 5.8 months for Keytruda. The results were stunning. So too was the nationality of the biotech company behind them. Akeso is Chinese.
This is exactly what I predicted in my TED talk and it’s great news! As I said then:
Ideas have this amazing property. Thomas Jefferson said “He who receives an idea from me receives instruction himself, without lessening mine. As he who lights his candle at mine receives light without darkening me.”
Now think about the following: if China and India were as rich as the United States is today, the market for cancer drugs would be eight times larger than it is now. Now we are not there yet, but it is happening. As other countries become richer the demand for these pharmaceuticals is going to increase tremendously. And that means an increase incentive to do research and development, which benefits everyone in the world. Larger markets increase the incentive to produce all kinds of ideas, whether it’s software, whether it’s a computer chip, whether it’s a new design.
Well if larger markets increase the incentive to produce new ideas, how do we maximize that incentive?
It’s by having one world market, by globalizing the world. Ideas are meant to be shared.
One idea, one world, one market.
Sadly, some of us are losing sight of the immense benefits of a global market. Another example of the great forgetting.
As Girard predicted, China’s growing similarity to the U.S. has fueled conflict and rivalry. But if managed properly, rivalry can be positive-sum. A rich China benefits us far more than a poor China—including by creating new cancer medicines that save American lives.
Hat tip: Cremieux.